Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Steven Edelman

    TitleClinical Professor
    SchoolUniversity of California, San Diego
    DepartmentMedicine
    Address9500 Gilman Drive #9111-G
    CA La Jolla 92093
    Phone858-552-8585
    vCardDownload vCard

      Collapse Research 
      Collapse Research Activities and Funding
      KINETICS OF IN VIVO GLUCOSE UPTAKE IN DIABETES
      NIH/NIDDK F32DK008271Apr 15, 1989
      Role: Principal Investigator

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Edelman S, Polonsky WH. Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control. Diabetes Care. 2017 Aug 11. PMID: 28801473.
        View in: PubMed
      2. Carls GS, Tuttle E, Tan RD, Huynh J, Yee J, Edelman S, Polonsky WH. Understanding the Gap Between Efficacy in Randomized Controlled Trials and Effectiveness in Real-World Use of GLP-1RA and DPP4 Therapies in Patients With Type 2 Diabetes. Diabetes Care. 2017 Aug 11. PMID: 28801475.
        View in: PubMed
      3. Berard L, Bonnemaire M, Mical M, Edelman S. Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative survey. Diabetes Obes Metab. 2017 Jul 18. PMID: 28719066.
        View in: PubMed
      4. Carls G, Huynh J, Tuttle E, Yee J, Edelman S. Achievement of Glycated Hemoglobin Goals in the US Remains Unchanged Through 2014. Diabetes Ther. 2017 Aug; 8(4):863-873. PMID: 28646411.
        View in: PubMed
      5. Capehorn M, Polonsky WH, Edelman S, Belton A, Down S, Gamerman V, Nagel F, Lee J, Alzaid A. Challenges faced by physicians when discussing the Type 2 diabetes diagnosis with patients: insights from a cross-national study (IntroDia® ). Diabet Med. 2017 Aug; 34(8):1100-1107. PMID: 28370335.
        View in: PubMed
      6. Edelman S, Hollander PA, Wright EE. Where Are We Now? A Clinicians' Guide to the Use of Follow-On Insulin for Patients with Diabetes. Am J Med. 2017 05; 130(5):614. PMID: 28431671.
        View in: PubMed
      7. Hirsch JD, Bounthavong M, Arjmand A, Ha DR, Cadiz CL, Zimmerman A, Ourth H, Morreale AP, Edelman S, Morello CM. Estimated Cost-Effectiveness, Cost Benefit, and Risk Reduction Associated with an Endocrinologist-Pharmacist Diabetes Intense Medical Management "Tune-Up" Clinic. J Manag Care Spec Pharm. 2017 Mar; 23(3):318-326. PMID: 28230459.
        View in: PubMed
      8. Heinemann L, Fritz I, Khatami H, Edelman S. Administration of Biosimilar Insulin Analogs: Role of Devices. Diabetes Technol Ther. 2017 Feb; 19(2):79-84. PMID: 28118050.
        View in: PubMed
      9. Polonsky WH, Fisher L, Hessler D, Edelman S. Investigating Hypoglycemic Confidence in Type 1 and Type 2 Diabetes. Diabetes Technol Ther. 2017 Feb; 19(2):131-136. PMID: 27997217.
        View in: PubMed
      10. Edelman S. Regulation Catches Up to Reality. J Diabetes Sci Technol. 2017 Jan; 11(1):160-164. PMID: 27630249.
        View in: PubMed
      11. Pettus J, Edelman S. Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM). J Diabetes Sci Technol. 2016 Sep; 10(5):1087-93. PMID: 27044518.
        View in: PubMed
      12. Pettus J, Edelman S. Recommendations for Using Real-Time Continuous Glucose Monitoring (rtCGM) Data for Insulin Adjustments in Type 1 Diabetes. J Diabetes Sci Technol. 2017 Jan; 11(1):138-147. PMID: 27530720.
        View in: PubMed
      13. McGill JB, Ahn D, Edelman S, Kilpatrick CR, Santos Cavaiola T. Making Insulin Accessible: Does Inhaled Insulin Fill an Unmet Need? Adv Ther. 2016 Aug; 33(8):1267-78. PMID: 27384191.
        View in: PubMed
      14. Spollett G, Edelman S, Mehner P, Walter C, Penfornis A. Improvement of Insulin Injection Technique: Examination of Current Issues and Recommendations. Diabetes Educ. 2016 Aug; 42(4):379-94. PMID: 27216036.
        View in: PubMed
      15. Ahn D, Pettus J, Edelman S. Unblinded CGM Should Replace Blinded CGM in the Clinical Management of Diabetes. J Diabetes Sci Technol. 2016 May; 10(3):793-8. PMID: 26884422.
        View in: PubMed
      16. Pettus J, Edelman S. Use of Glucose Rate of Change Arrows to Adjust Insulin Therapy Among Individuals with Type 1 Diabetes Who Use Continuous Glucose Monitoring. Diabetes Technol Ther. 2016 Feb; 18 Suppl 2:S234-42. PMID: 26784128; PMCID: PMC4717500.
      17. Ilag LL, Deeg MA, Costigan T, Hollander P, Blevins TC, Edelman S, Konrad RJ, Ortmann RA, Pollom RK, Huster WJ, Zielonka JS, Prince MJ. Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus. Diabetes Obes Metab. 2016 Feb; 18(2):159-68. PMID: 26434665; PMCID: PMC4737399.
      18. Pettus J, Santos Cavaiola T, Tamborlane WV, Edelman S. The past, present, and future of basal insulins. Diabetes Metab Res Rev. 2016 Sep; 32(6):478-96. PMID: 26509843.
        View in: PubMed
      19. Morello CM, Christopher ML, Ortega L, Khoan J, Rotunno T, Edelman S, Henry RR, Hirsch JD. Clinical Outcomes Associated With a Collaborative Pharmacist-Endocrinologist Diabetes Intense Medical Management "Tune Up" Clinic in Complex Patients. Ann Pharmacother. 2016 Jan; 50(1):8-16. PMID: 26546580.
        View in: PubMed
      20. Peters AL, Pollom RD, Zielonka JS, Carey MA, Edelman S. BIOSIMILARS AND NEW INSULIN VERSIONS. Endocr Pract. 2015 Dec; 21(12):1387-94. PMID: 26340139.
        View in: PubMed
      21. Polonsky WH, Fisher L, Hessler D, Edelman S. Identifying the worries and concerns about hypoglycemia in adults with type 2 diabetes. J Diabetes Complications. 2015 Nov-Dec; 29(8):1171-6. PMID: 26338296.
        View in: PubMed
      22. Polonsky WH, Fisher L, Hessler D, Edelman S. Development of a New Measure for Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes. Diabetes Technol Ther. 2015 Nov; 17(11):773-9. PMID: 26167948.
        View in: PubMed
      23. Polonsky WH, Fisher L, Hessler D, Edelman S. Development of a New Measure for Assessing Glucose Monitoring Device-Related Treatment Satisfaction and Quality of Life. Diabetes Technol Ther. 2015 Sep; 17(9):657-63. PMID: 25923812.
        View in: PubMed
      24. Pettus J, Price DA, Edelman S. HOW PATIENTS WITH TYPE 1 DIABETES TRANSLATE CONTINUOUS GLUCOSE MONITORING DATA INTO DIABETES MANAGEMENT DECISIONS. Endocr Pract. 2015 Jun; 21(6):613-20. PMID: 25716635.
        View in: PubMed
      25. Edelman S, Liu R, Johnson J, Glass LC. Response to comment on Edelman et al. AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes. Diabetes Care 2014;37:2132-2140. Diabetes Care. 2014 Dec; 37(12):e263-4. PMID: 25414399.
        View in: PubMed
      26. Edelman S. Comment on Little et al. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care 2014;37:2114-2122. Diabetes Care. 2014 Dec; 37(12):e270-1. PMID: 25414404.
        View in: PubMed
      27. David G, Gill M, Gunnarsson C, Shafiroff J, Edelman S. Switching from multiple daily injections to CSII pump therapy: insulin expenditures in type 2 diabetes. Am J Manag Care. 2014 Nov 01; 20(11):e490-7. PMID: 25730348.
        View in: PubMed
      28. Edelman S, Pettus J. Challenges associated with insulin therapy in type 2 diabetes mellitus. Am J Med. 2014 Oct; 127(10 Suppl):S11-6. PMID: 25282008.
        View in: PubMed
      29. Henry RR, Rosenstock J, Edelman S, Mudaliar S, Chalamandaris AG, Kasichayanula S, Bogle A, Iqbal N, List J, Griffen SC. Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study. Diabetes Care. 2015 Mar; 38(3):412-9. PMID: 25271207.
        View in: PubMed
      30. Sarikonda G, Sachithanantham S, Pettus J, Rodriguez-Calvo T, Phatak S, Edelman S, von Herrath M. Higher proinflammatory cytokine production and spontaneous activation in some type 1 and type 2 diabetic subjects. Clin Immunol. 2014 Nov; 155(1):27-9. PMID: 25173803.
        View in: PubMed
      31. Edelman S, Polonsky WH, Parkin CG. Biosimilar insulins are coming: what they are, what you need to know. Curr Med Res Opin. 2014 Nov; 30(11):2217-22. PMID: 25105307.
        View in: PubMed
      32. Santos Cavaiola T, Edelman S. Inhaled insulin: a breath of fresh air? A review of inhaled insulin. Clin Ther. 2014 Aug 01; 36(8):1275-89. PMID: 25044021.
        View in: PubMed
      33. Pettus J, Stenger P, Schachner HC, Dunne N, Parkes JL, Pardo S, Edelman S. Testing versus guessing blood glucose values: impact on self-care behaviors in type 2 diabetes. Curr Med Res Opin. 2014 Sep; 30(9):1795-802. PMID: 24889281.
        View in: PubMed
      34. Edelman S, Ng-Mak DS, Fusco M, Ashton D, Okerson T, Liu Q, Jin J, Dixon JB. Control of type 2 diabetes after 1 year of laparoscopic adjustable gastric banding in the helping evaluate reduction in obesity (HERO) study. Diabetes Obes Metab. 2014 Oct; 16(10):1009-15. PMID: 24824326.
        View in: PubMed
      35. Blumer I, Edelman S. Biosimilar insulins are coming: the top 10 things you should know. Postgrad Med. 2014 May; 126(3):107-10. PMID: 24918796.
        View in: PubMed
      36. Edelman S, Liu R, Johnson J, Glass LC. AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes. Diabetes Care. 2014 Aug; 37(8):2132-40. PMID: 24742662.
        View in: PubMed
      37. Edelman S, Blose JS. The Impact of Nocturnal Hypoglycemia on Clinical and Cost-Related Issues in Patients With Type 1 and Type 2 Diabetes. Diabetes Educ. 2014 May; 40(3):269-279. PMID: 24695260.
        View in: PubMed
      38. Stauder U, Enginee D, Elton H, Penfornis A, Edelman S. Comparative Assessment of Lixisenatide, Exenatide, and Liraglutide Pen Devices: A Pilot User-Based Study. J Diabetes Sci Technol. 2014 Jan; 8(1):123-131. PMID: 24876548.
        View in: PubMed
      39. Dolinar RO, Edelman S, Heinemann L, Home P, Goyal S, Polonsky WH, Schellekens H. Impact of Biosimilar Insulins on Clinical Practice: Meeting Report. J Diabetes Sci Technol. 2014 Jan; 8(1):179-185. PMID: 24876554.
        View in: PubMed
      40. Sarikonda G, Pettus J, Phatak S, Sachithanantham S, Miller JF, Wesley JD, Cadag E, Chae J, Ganesan L, Mallios R, Edelman S, Peters B, von Herrath M. CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes. J Autoimmun. 2014 May; 50:77-82. PMID: 24387802.
        View in: PubMed
      41. Sarikonda G, Pettus J, Sachithanantham S, Phatak S, Miller JF, Ganesan L, Chae J, Mallios R, Edelman S, Peters B, von Herrath M. Temporal intra-individual variation of immunological biomarkers in type 1 diabetes patients: implications for future use in cross-sectional assessment. PLoS One. 2013; 8(11):e79383. PMID: 24223938; PMCID: PMC3817042.
      42. Boland BS, Edelman S, Wolosin JD. Gastrointestinal complications of diabetes. Endocrinol Metab Clin North Am. 2013 Dec; 42(4):809-32. PMID: 24286951.
        View in: PubMed
      43. Polonsky WH, Fisher L, Hessler D, Edelman S. What is so tough about self-monitoring of blood glucose? Perceived obstacles among patients with Type 2 diabetes. Diabet Med. 2014 Jan; 31(1):40-6. PMID: 23819529.
        View in: PubMed
      44. Herrmann K, Frias JP, Edelman S, Lutz K, Shan K, Chen S, Maggs D, Kolterman OG. Pramlintide improved measures of glycemic control and body weight in patients with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapy. Postgrad Med. 2013 May; 125(3):136-44. PMID: 23748514.
        View in: PubMed
      45. Pettus J, Hirsch I, Edelman S. GLP-1 agonists in type 1 diabetes. Clin Immunol. 2013 Dec; 149(3):317-23. PMID: 23643354.
        View in: PubMed
      46. Edelman S, Bhoyrul S, Billy H, Cornell C, Okerson T. Effect of early weight loss on type 2 diabetes mellitus after 2 years of gastric banding. Postgrad Med. 2012 Nov; 124(6):73-81. PMID: 23322140.
        View in: PubMed
      47. Hirsch IB, Amiel SA, Blumer IR, Bode BW, Edelman S, Seley JJ, Verderese CA, Kilpatrick ES. Using multiple measures of glycemia to support individualized diabetes management: recommendations for clinicians, patients, and payers. Diabetes Technol Ther. 2012 Nov; 14(11):973-83; quiz 983. PMID: 23066850.
        View in: PubMed
      48. Blumer I, Edelman S, Hirsch IB. Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med. 2012 Jul 26; 367(4):383; author reply 383-4. PMID: 22830479.
        View in: PubMed
      49. Polonsky WH, Fisher L, Hessler D, Edelman S. A survey of blood glucose monitoring in patients with type 2 diabetes: are recommendations from health care professionals being followed? Curr Med Res Opin. 2011 Nov; 27 Suppl 3:31-7. PMID: 22106976.
        View in: PubMed
      50. Frias JP, Bode BW, Bailey TS, Kipnes MS, Brunelle R, Edelman S. A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections. J Diabetes Sci Technol. 2011 Jul 01; 5(4):887-93. PMID: 21880230; PMCID: PMC3192594.
      51. Villa-Caballero L, Morello CM, Chynoweth ME, Prieto-Rosinol A, Polonsky WH, Palinkas LA, Edelman S. Ethnic differences in complementary and alternative medicine use among patients with diabetes. Complement Ther Med. 2010 Dec; 18(6):241-8. PMID: 21130360; PMCID: PMC3003303.
      52. Kulasa K, Edelman S. Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus. Core Evid. 2010 Oct 21; 5:23-37. PMID: 21042540; PMCID: PMC2963920.
      53. Polonsky WH, Fisher L, Guzman S, Sieber WJ, Philis-Tsimikas A, Edelman S. Are patients' initial experiences at the diagnosis of type 2 diabetes associated with attitudes and self-management over time? Diabetes Educ. 2010 Sep-Oct; 36(5):828-34. PMID: 20729511.
        View in: PubMed
      54. Edelman S, Bode BW, Bailey TS, Kipnes MS, Brunelle R, Chen X, Frias JP. Insulin pump therapy in patients with type 2 diabetes safely improved glycemic control using a simple insulin dosing regimen. Diabetes Technol Ther. 2010 Aug; 12(8):627-33. PMID: 20615104.
        View in: PubMed
      55. Bailey TS, Edelman S. Insulin pen use for type 2 diabetes--a clinical perspective. Diabetes Technol Ther. 2010 Jun; 12 Suppl 1:S86-90. PMID: 20515313.
        View in: PubMed
      56. Edelman S, Bailey TS. Continuous glucose monitoring health outcomes. Diabetes Technol Ther. 2009 Jun; 11 Suppl 1:S68-74. PMID: 19469680.
        View in: PubMed
      57. Fischer JS, Edelman S, Schwartz SL. United States patient preference and usability for the new disposable insulin device Solostar versus other disposable pens. J Diabetes Sci Technol. 2008 Nov; 2(6):1157-60. PMID: 19885306; PMCID: PMC2769811.
      58. Edelman S. Does addition of pramlintide to basal insulin improve glycemic control in type 2 diabetes mellitus? Nat Clin Pract Endocrinol Metab. 2008 Apr; 4(4):194-5. PMID: 18283327.
        View in: PubMed
      59. Edelman S, Maier H, Wilhelm K. Pramlintide in the treatment of diabetes mellitus. BioDrugs. 2008; 22(6):375-86. PMID: 18998755.
        View in: PubMed
      60. Edelman S. Optimizing diabetes treatment using an amylin analogue. Diabetes Educ. 2008 Jan-Feb; 34 Suppl 1:4S-10S. PMID: 18268000.
        View in: PubMed
      61. Choe C, Edelman S. The role of self-monitoring of blood glucose during the treatment of type 2 diabetes with medications targeting postprandial hyperglycemia. South Med J. 2007 Nov; 100(11):1123-31. PMID: 17984745.
        View in: PubMed
      62. Frias JP, Edelman S. Incretins and their role in the management of diabetes. Curr Opin Endocrinol Diabetes Obes. 2007 Aug; 14(4):269-76. PMID: 17940451.
        View in: PubMed
      63. Edelman S, Garg S, Kolterman OG. Is pramlintide a safe and effective adjunct therapy for patients with type 1 diabetes? Nat Clin Pract Endocrinol Metab. 2007 May; 3(5):E1; discussion E2. PMID: 17452962.
        View in: PubMed
      64. Edelman S, Dailey G, Flood T, Kuritzky L, Renda S. A practical approach for implementation of a basal-prandial insulin therapy regimen in patients with type 2 diabetes. Osteopath Med Prim Care. 2007 Apr 20; 1:9. PMID: 17448241; PMCID: PMC1885266.
      65. Haak T, Edelman S, Walter C, Lecointre B, Spollett G. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study. Clin Ther. 2007 Apr; 29(4):650-60. PMID: 17617288.
        View in: PubMed
      66. Choe C, Edelman S. New therapeutic options for treating type-2 diabetes: a review of insulin analogs and premixed insulin analogs. J Natl Med Assoc. 2007 Apr; 99(4):357-60, 363-7. PMID: 17444424; PMCID: PMC2569656.
      67. Raine CH, Schrock LE, Edelman S, Mudaliar SR, Zhong W, Proud LJ, Parkes JL. Significant insulin dose errors may occur if blood glucose results are obtained from miscoded meters. J Diabetes Sci Technol. 2007 Mar; 1(2):205-10. PMID: 19888408; PMCID: PMC2771463.
      68. Kruger DF, Aronoff SL, Edelman S. Through the looking glass: current and future perspectives on the role of hormonal interplay in glucose homeostasis. Diabetes Educ. 2007 Feb; 33 Suppl 2:32S-46S; quiz 47S-48S. PMID: 17483531.
        View in: PubMed
      69. Edelman S, Darsow T, Frias JP. Pramlintide in the treatment of diabetes. Int J Clin Pract. 2006 Dec; 60(12):1647-53. PMID: 17109671.
        View in: PubMed
      70. Edelman S, Garg S, Frias J, Maggs D, Wang Y, Zhang B, Strobel S, Lutz K, Kolterman O. A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes. Diabetes Care. 2006 Oct; 29(10):2189-95. PMID: 17003291.
        View in: PubMed
      71. Edelman S, Caballero L. Amylin replacement therapy in patients with type 1 diabetes. Diabetes Educ. 2006 May-Jun; 32 Suppl 3:119S-127S. PMID: 16751353.
        View in: PubMed
      72. Edelman S. Does a patient-administered titration algorithm of insulin glargine improve glycemic control? Nat Clin Pract Endocrinol Metab. 2006 Feb; 2(2):78-9. PMID: 16932261.
        View in: PubMed
      73. Edelman S. Incretins: what does the future hold? Diabetes Technol Ther. 2005 Oct; 7(5):809-12. PMID: 16241889.
        View in: PubMed
      74. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman S. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005 Oct; 28(10):2543-5. PMID: 16186296.
        View in: PubMed
      75. Edelman S, Morello CM. Strategies for insulin therapy in type 2 diabetes. South Med J. 2005 Mar; 98(3):363-71. PMID: 15813164.
        View in: PubMed
      76. Edelman S. Thiazolidinediones. N Engl J Med. 2005 Jan 13; 352(2):205-7; author reply 205-7. PMID: 15651124.
        View in: PubMed
      77. Edelman S, Morello CM. Hypoglycemia unawareness and type 1 diabetes. South Med J. 2004 Nov; 97(11):1143-4. PMID: 15586620.
        View in: PubMed
      78. Ciaraldi TP, Mudaliar S, Barzin A, Macievic JA, Edelman S, Park KS, Henry RR. Skeletal muscle GLUT1 transporter protein expression and basal leg glucose uptake are reduced in type 2 diabetes. J Clin Endocrinol Metab. 2005 Jan; 90(1):352-8. PMID: 15483099.
        View in: PubMed
      79. Bhalla MA, Chiang A, Epshteyn VA, Kazanegra R, Bhalla V, Clopton P, Krishnaswamy P, Morrison LK, Chiu A, Gardetto N, Mudaliar S, Edelman S, Henry RR, Maisel AS. Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. J Am Coll Cardiol. 2004 Sep 01; 44(5):1047-52. PMID: 15337217.
        View in: PubMed
      80. Davis T, Edelman S. Insulin therapy in type 2 diabetes. Med Clin North Am. 2004 Jul; 88(4):865-95, x. PMID: 15308383.
        View in: PubMed
      81. Garg SK, Schwartz S, Edelman S. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care. 2004 Mar; 27(3):734-8. PMID: 14988294.
        View in: PubMed
      82. Chu NV, Edelman S. BNP levels to screen for left ventricular dysfunction. Curr Diab Rep. 2004 Feb; 4(1):39-40. PMID: 14764278.
        View in: PubMed
      83. Epshteyn V, Morrison K, Krishnaswamy P, Kazanegra R, Clopton P, Mudaliar S, Edelman S, Henry R, Maisel A. Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. Diabetes Care. 2003 Jul; 26(7):2081-7. PMID: 12832317.
        View in: PubMed
      84. Chau DL, Edelman S, Chandran M. Osteoporosis and diabetes. Curr Diab Rep. 2003 Feb; 3(1):37-42. PMID: 12643144.
        View in: PubMed
      85. Chandran M, Chu NV, Edelman S. Gastrointestinal disturbances in diabetes. Curr Diab Rep. 2003 Feb; 3(1):43-8. PMID: 12643145.
        View in: PubMed
      86. Chu NV, Edelman S. Pramlintide as an adjunct to insulin therapy. Curr Diab Rep. 2003 Feb; 3(1):35-6. PMID: 12685439.
        View in: PubMed
      87. Edelman S. The role of the thiazolidinediones in the practical management of patients with type 2 diabetes and cardiovascular risk factors. Rev Cardiovasc Med. 2003; 4 Suppl 6:S29-37. PMID: 14668701.
        View in: PubMed
      88. Buse JB, Freeman JL, Edelman S, Jovanovic L, McGill JB. Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker. Diabetes Technol Ther. 2003; 5(3):355-63. PMID: 12828817.
        View in: PubMed
      89. Edelman S. Aiming for, believing in, and achieving a target A1c of less than 7. J Am Pharm Assoc (Wash). 2003 Jan-Feb; 43(1):121-2. PMID: 12585763.
        View in: PubMed
      90. Edelman S. Aiming for, believing in, and achieving a target a1c of less than 7. J Am Pharm Assoc (Wash). 2003 Jan; 43(1):121-2. PMID: 23945818.
        View in: PubMed
      91. Edelman S. Pumps and type 2 diabetes. If you can improve your diabetes control, and if you can accommodate yourself to it, the pump might just be the best diabetes therapy for you. Diabetes Forecast. 2002 Jun; 55(6):62-5. PMID: 14964172.
        View in: PubMed
      92. Chu NV, Edelman S. Erectile dysfunction and diabetes. Curr Diab Rep. 2002 Feb; 2(1):60-6. PMID: 12643124.
        View in: PubMed
      93. Edelman S. Insulin pump therapy versus multiple daily injections. Curr Diab Rep. 2002 Feb; 2(1):47-8. PMID: 15279019.
        View in: PubMed
      94. Edelman S, Weyer C. Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second beta-cell hormone. Diabetes Technol Ther. 2002; 4(2):175-89. PMID: 12079621.
        View in: PubMed
      95. Sarno MJ, Bell J, Edelman S. Pharmacokinetics and glucodynamics of rapid-, short-, and intermediate-acting insulins: comparison of jet injection to needle syringe. Diabetes Technol Ther. 2002; 4(6):863-6. PMID: 12614490.
        View in: PubMed
      96. Mudaliar S, Edelman S. Insulin therapy in type 2 diabetes. Endocrinol Metab Clin North Am. 2001 Dec; 30(4):935-82. PMID: 11727406.
        View in: PubMed
      97. Edelman S, Bell JM, Serrano RB, Kelemen D. Home testing of fructosamine improves glycemic control in patients with diabetes. Endocr Pract. 2001 Nov-Dec; 7(6):454-8. PMID: 11747282.
        View in: PubMed
      98. Edelman S. Does measuring fructosamine help patients with diabetes? Eff Clin Pract. 2001 Jul-Aug; 4(4):189-90. PMID: 11525109.
        View in: PubMed
      99. Pitzer KR, Desai S, Dunn T, Edelman S, Jayalakshmi Y, Kennedy J, Tamada JA, Potts RO. Detection of hypoglycemia with the GlucoWatch biographer. Diabetes Care. 2001 May; 24(5):881-5. PMID: 11347748.
        View in: PubMed
      100. Edelman S. Watching your glucose with the GlucoWatch. Diabetes Technol Ther. 2001; 3(2):283-4. PMID: 11478336.
        View in: PubMed
      101. Bremer TM, Edelman S, Gough DA. Benchmark data from the literature for evaluation of new glucose sensing technologies. Diabetes Technol Ther. 2001; 3(3):409-18. PMID: 11762520.
        View in: PubMed
      102. Mather K, Laakso M, Edelman S, Hook G, Baron A. Evidence for physiological coupling of insulin-mediated glucose metabolism and limb blood flow. Am J Physiol Endocrinol Metab. 2000 Dec; 279(6):E1264-70. PMID: 11093913.
        View in: PubMed
      103. Pascoe S, Edelman S, Kidman A. Prevalence of psychological distress and use of support services by cancer patients at Sydney hospitals. Aust N Z J Psychiatry. 2000 Oct; 34(5):785-91. PMID: 11037364.
        View in: PubMed
      104. Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, Donofrio P, Cornblath D, Olson WH, Kamin M. Maintenance of the long-term effectiveness of tramadol in treatment of the pain of diabetic neuropathy. J Diabetes Complications. 2000 Mar-Apr; 14(2):65-70. PMID: 10959067.
        View in: PubMed
      105. Marrero D, Edelman S. Hypoglycemia and driving performance: a flashing yellow light? Diabetes Care. 2000 Feb; 23(2):146-7. PMID: 10868820.
        View in: PubMed
      106. Edelman S, Callahan P, Deeb LC. Multisite evaluation of a new diabetes self-test for glucose and glycated protein (fructosamine). Diabetes Technol Ther. 2000; 2(2):233-8. PMID: 11469264.
        View in: PubMed
      107. Ramlo-Halsted BA, Edelman S. The natural history of type 2 diabetes. Implications for clinical practice. Prim Care. 1999 Dec; 26(4):771-89. PMID: 10523459.
        View in: PubMed
      108. Peters AL, Henry R, Edelman S, Goldstein BJ. Keep metformin guidelines intact. Diabetes Care. 1999 Mar; 22(3):532-3. PMID: 10097947.
        View in: PubMed
      109. Duckworth WC, Saudek CD, Giobbie-Hurder A, Henderson WG, Henry RR, Kelley DE, Edelman S, Zieve FJ, Adler RA, Anderson JW, Anderson RJ, Hamilton BP, Donner TW, Kirkman MS, Morgan NA. The Veterans Affairs Implantable Insulin Pump Study: effect on cardiovascular risk factors. Diabetes Care. 1998 Oct; 21(10):1596-602. PMID: 9773717.
        View in: PubMed
      110. Edelman S. Importance of glucose control. Med Clin North Am. 1998 Jul; 82(4):665-87. PMID: 9706116.
        View in: PubMed
      111. Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, Donofrio P, Cornblath D, Sachdeo R, Siu CO, Kamin M. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology. 1998 Jun; 50(6):1842-6. PMID: 9633738.
        View in: PubMed
      112. Edelman S. Type II diabetes mellitus. Adv Intern Med. 1998; 43:449-500. PMID: 9506190.
        View in: PubMed
      113. Edelman S, Henry RR. Non-insulin-dependent diabetes mellitus. Curr Ther Endocrinol Metab. 1997; 6:430-8. PMID: 9174785.
        View in: PubMed
      114. Kelley DE, Henry RR, Edelman S. Acute effects of intraperitoneal versus subcutaneous insulin delivery on glucose homeostasis in patients with NIDDM. Veterans Affairs Implantable Insulin Pump Study Group. Diabetes Care. 1996 Nov; 19(11):1237-42. PMID: 8908387.
        View in: PubMed
      115. Saudek CD, Duckworth WC, Giobbie-Hurder A, Henderson WG, Henry RR, Kelley DE, Edelman S, Zieve FJ, Adler RA, Anderson JW, Anderson RJ, Hamilton BP, Donner TW, Kirkman MS, Morgan NA. Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group. JAMA. 1996 Oct 23-30; 276(16):1322-7. PMID: 8861991.
        View in: PubMed
      116. Edelman S. New orally administered antihyperglycemic agents for the management of patients with type ii diabetes and the syndrome of insulin resistance. Endocr Pract. 1996 Jul-Aug; 2(4):271-5. PMID: 15251529.
        View in: PubMed
      117. Rodriguez JA, Saddler S, Edelman S, Ranawat CS. Long-term results of total knee arthroplasty in class 3 and 4 rheumatoid arthritis. J Arthroplasty. 1996 Feb; 11(2):141-5. PMID: 8648306.
        View in: PubMed
      118. Reaven PD, Herold DA, Barnett J, Edelman S. Effects of Vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM. Diabetes Care. 1995 Jun; 18(6):807-16. PMID: 7555507.
        View in: PubMed
      119. Tate KM, Lee C, Edelman S, Carswell-Crumpton C, Liblau R, Jones PP. Interactions among polymorphic and conserved residues in MHC class II proteins affect MHC-peptide conformation and T cell recognition. Int Immunol. 1995 May; 7(5):747-61. PMID: 7547702.
        View in: PubMed
      120. Edelman S. Diabetes epidemic. Med Sect Proc. 1994; 27-44. PMID: 7659716.
        View in: PubMed
      121. Laakso M, Edelman S, Brechtel G, Baron AD. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes. 1992 Sep; 41(9):1076-83. PMID: 1499861.
        View in: PubMed
      122. Laakso M, Edelman S, Brechtel G, Baron AD. Effects of epinephrine on insulin-mediated glucose uptake in whole body and leg muscle in humans: role of blood flow. Am J Physiol. 1992 Aug; 263(2 Pt 1):E199-204. PMID: 1514599.
        View in: PubMed
      123. Henry RR, Edelman S. Advances in treatment of type II diabetes mellitus in the elderly. Geriatrics. 1992 Apr; 47(4):24-30. PMID: 1555777.
        View in: PubMed
      124. Baron AD, Laakso M, Brechtel G, Edelman S. Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metab. 1991 Sep; 73(3):637-43. PMID: 1874938.
        View in: PubMed
      125. Baron AD, Laakso M, Brechtel G, Edelman S. Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy. J Clin Invest. 1991 Apr; 87(4):1186-94. PMID: 2010535; PMCID: PMC295132.
      126. Laakso M, Edelman S, Olefsky JM, Brechtel G, Wallace P, Baron AD. Kinetics of in vivo muscle insulin-mediated glucose uptake in human obesity. Diabetes. 1990 Aug; 39(8):965-74. PMID: 2197140.
        View in: PubMed
      127. Edelman S, Laakso M, Wallace P, Brechtel G, Olefsky JM, Baron AD. Kinetics of insulin-mediated and non-insulin-mediated glucose uptake in humans. Diabetes. 1990 Aug; 39(8):955-64. PMID: 1973673.
        View in: PubMed
      128. Baron AD, Laakso M, Brechtel G, Hoit B, Watt C, Edelman S. Reduced postprandial skeletal muscle blood flow contributes to glucose intolerance in human obesity. J Clin Endocrinol Metab. 1990 Jun; 70(6):1525-33. PMID: 2189883.
        View in: PubMed
      129. Laakso M, Edelman S, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest. 1990 Jun; 85(6):1844-52. PMID: 2189893; PMCID: PMC296649.
      130. Molina JM, Baron AD, Edelman S, Brechtel G, Wallace P, Olefsky JM. Use of a variable tracer infusion method to determine glucose turnover in humans. Am J Physiol. 1990 Jan; 258(1 Pt 1):E16-23. PMID: 2405697.
        View in: PubMed
      131. Baron AD, Brechtel G, Edelman S. Effects of free fatty acids and ketone bodies on in vivo non-insulin-mediated glucose utilization and production in humans. Metabolism. 1989 Nov; 38(11):1056-61. PMID: 2682134.
        View in: PubMed
      132. Edelman S, Witztum JL. Hyperkalemia during treatment with HMG-CoA reductase inhibitor. N Engl J Med. 1989 May 04; 320(18):1219-20. PMID: 2710198.
        View in: PubMed
      133. Baron AD, Brechtel G, Wallace P, Edelman S. Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol. 1988 Dec; 255(6 Pt 1):E769-74. PMID: 3059816.
        View in: PubMed
      134. Baron AD, Brechtel G, Wallace P, Edelman S. Fasting decreases rates of noninsulin-mediated glucose uptake in man. J Clin Endocrinol Metab. 1988 Sep; 67(3):532-40. PMID: 3045143.
        View in: PubMed
      135. Edelman S, Kosofsky EM, Paul RA, Kozak GP. Neuro-osteoarthropathy (Charcot's joint) in diabetes mellitus following revascularization surgery. Three case reports and a review of the literature. Arch Intern Med. 1987 Aug; 147(8):1504-8. PMID: 3632157.
        View in: PubMed
      136. Fighali S, Krajcer Z, Edelman S, Leachman RD. Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction. J Am Coll Cardiol. 1987 Feb; 9(2):288-94. PMID: 3805517.
        View in: PubMed
      137. Scharf Y, Nahir M, Tatarsky I, Arieh JB, Baruch G, Edelman S. Fatal venous thrombosis in hyperosmolar coma. Diabetes. 1971 May; 20(5):308-9. PMID: 5581320.
        View in: PubMed